Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Under a 2017 policy implemented by Beijing to expand access to various medicines, drugmakers have to negotiate their prices directly with the government if they want their products to be covered by China's state-funded medical insurance scheme
PMCID: PMC2878077
First, the provider with the lowest starting price isn't necessarily the most affordable provider over the course of a full treatment cycle
Huber M, Lezius S, Reibis R, Treszl A, Kujawinska D, Jakob S, et al
313 Several therapeutic approaches targeting Met metabolism, including Met restriction, MAT2A inhibitors IDE397 and AG-270, are in clinical trials, and their therapeutic effects need to be verified
-1775582746855.png&w=3840&q=75)
Seo S, Ju S, Chung H, Lee D, Park S
US$ 27.56
US$ 23.61
US$ 24.37
US$ 25.83
